Beta-cryptoxanthin and lung cancer in Shanghai, China - An examination of potential confounding with cigarette smoking using urinary cotinine as a biomarker for true tobacco exposure

被引:6
|
作者
Stram, Daniel O. [1 ]
Yuan, Jian-Min
Chan, Kenneth K.
Gao, Yu-Tang
Ross, Ronald K.
Yu, Mimi C.
机构
[1] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA
[2] Univ Minnesota, Ctr Canc, Minneapolis, MN 55455 USA
[3] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA
[4] Shanghai Canc Inst, Dept Epidemiol, Shanghai 200032, Peoples R China
来源
关键词
D O I
10.1080/01635580701273998
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Diet may be a modifier of smoking-related cancer risk, with protective effects of intake of fruits and vegetables and associated antioxidants found in many observational studies. We previously reported serum beta-cryptoxanthin levels being inversely associated with smoking-related lung cancer incidence in a cohort of Chinese men. We noted, however, that serum beta-cryptoxanthin is negatively correlated with smoking. Since self-reports of smoking intensity undoubtedly containing errors, this negative correlation indicates a potential bias in assessing the effects of beta-cryptoxanthin, due to confounding with the unmeasured (residual) portion of cigarette exposure. We evaluated cotinine levels in pre-diagnostic spot urine samples to attempt to improve smoking assessment. We noted that urinary cotinine levels correlated significantly with cigarette consumption overall and that cotinine was strongly predictive of lung cancer risk. Urinary cotinine, however, was not as strong a predictor of lung cancer risk in current smokers as ivere self-reports of cigarette consumption and cotinine remained only a marginally significant predictor of lung cancer risk after adjustment for self-reports. An apparent benefit of beta-cryptoxanthin remained evident when including both urinary cotinine and self-reported cigarette consumption and cotinine in the statistical model. However, we conclude that cotinine measured from a single spot urine seems to have only limited value in augmenting self-reports of cigarette consumption so that, at present, the apparent protective effects of beta-cryptoxanthin, as seen in our own study, should continue to be regarded as unproven. We believe that future epidemiological evaluation of the association between beta-cryptoxanthin (and other antioxidants) and reduced lung cancer risk must utilize improved biomarkers to augment smokers own self-reports of smoking amount.
引用
收藏
页码:123 / 129
页数:7
相关论文
共 1 条
  • [1] Urinary Cotinine Is as Good a Biomarker as Serum Cotinine for Cigarette Smoking Exposure and Lung Cancer Risk Prediction
    Thomas, Claire E.
    Wang, Renwei
    Adams-Haduch, Jennifer
    Murphy, Sharon E.
    Ueland, Per Magne
    Midttun, Oivind
    Brennan, Paul
    Johansson, Mattias
    Gao, Yu-Tang
    Yuan, Jian-Min
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2020, 29 (01) : 127 - 132